Name: Electroporation of Plasmid DNA into Mouse Skeletal Muscle (Video) | JoVE Journal
Uploaded: 2022-04-06T15:00:00.000+00:00
Duration: 6 min 20 s
Description: Learn electroporation-mediated gene transfer in mouse skeletal muscle using C57BL/6 mice. This technique enables efficient plasmid DNA delivery without compromising muscle contractility for physiology research.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

All experiments using animals were performed at the Penn State College of Medicine, approved by Penn State University&#39;s Institutional Animal Care and Use Committee, and performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. 12-week-old female C57BL/6 mice were used for this procedure. All surgical tools were autoclaved for sterility prior to experimentation.
1. TA and EDL injection/electroporation preparation
NOTE: These steps are identical for TA and EDL injection/electroporation preparation.
<ol>
	<li>Purify expression plasmid constructs to a concentration of 1 &#181;g/&#181;L diluted in sterile PBS prior to the experiment. For this procedure, a commercially available endotoxin-free purification kit was used to purify pcDNA3-EGFP (GFP) or pcDNA3 empty vector (control).</li>
	<li>Calculate the plasmid concentration to ensure adequate injection volume (TA 50 &#181;g of DNA in 50 &#181;L of sterile PBS; EDL 10 &#181;g of DNA in 10 &#181;L of sterile PBS) and aliquot samples.</li>
	<li>Program the electroporator settings by using the select wheel and depressing the wheel to choose the parameters as follows: Mode - LV, Voltage - 12.5 V/mm (to be adjusted at the time of injection), pulse length - 20 ms, number of pulses - 5, interval - 200 ms, polarity - unipolar.</li>
	<li>Anesthetize the mice using isoflurane gas. Place the mice in an induction box with 5% isoflurane. Confirm the surgical plane of anesthesia by the absence of the toe pinch reflex using forceps and reduce isoflurane to 2% maintenance dose. Transfer mice to an appropriate nose cone resting on a circulating water plate at 37 &#176;C for the rest of the procedure.</li>
	<li>Remove hair from both hindlimbs using small hair clippers. Scrub the lower limbs with alternating 70% ethanol/betadine to sanitize the injection area.</li>
</ol>
2. TA injection/electroporation
<ol>
	<li>With the mouse in a supine position, locate the TA tendon visible through the skin on the lateral side of the lower leg. Using a 50 &#181;L micro-syringe with a detachable 30 G needle, insert the needle 1-2 mm superior to the myotendinous junction at a shallow 5&#176; angle until the needle reaches the superior end of the muscle. 
	NOTE: Injection into the middle of the muscle is the goal.</li>
	<li>Slowly depress the plunger while slowly retracting the needle along the injection path to deliver 50 &#181;L of plasmid solution. The muscle should swell.</li>
	<li>Set the timer for 1 min and measure the thickness of the leg at the TA. Depending on the size of the mouse, this can be from 5-10 mm. Set the caliper electrodes to the measured thickness and set the electroporator voltage to 12.5 V/mm.</li>
	<li>After 1 min, place the caliper electrodes around the lower limb. The electrodes should be snug but not overly tight. Deliver 5 square-wave pulses, with 20 ms duration and 200 ms intervals (the muscle should twitch with each pulse).</li>
	<li>Repeat with the alternate limb using the control vector.</li>
	<li>Remove the mouse from anesthesia and allow it to recover on a heating pad set to 37 &#176;C. Once recovered, return the mouse to its cage.</li>
</ol>
3. EDL injection/electroporation
<ol>
	<li>With the mouse in a supine position, locate the tibia bone anterior crest visually and through gentle palpation.
	<ol>
		<li>Using a scalpel, make a shallow incision through the skin on the lateral side of the tibia anterior crest 5 mm inferior to the knee to 2 mm superior to the TA myotendinous junction.</li>
		<li>Using small scissors, blunt dissect the fascia, exposing the TA muscle.</li>
		<li>Again, using blunt dissection with scissors, separate the TA muscle from the tibia gently by pulling the muscle laterally, exposing the EDL. Small, curved forceps can be used to keep the TA clear from the EDL during the procedure.</li>
	</ol>
	</li>
	<li>Using a 50 &#181;L micro-syringe with a detachable 30 G needle, insert the needle into the EDL longitudinally until the needle reaches the superior end of the muscle.</li>
	<li>Slowly depress the plunger while slowly retracting the needle along the injection path to inject 10 &#181;L of the plasmid solution (muscle should swell).</li>
	<li>Set a timer for 1 min and measure the thickness of the leg at the EDL. Depending on the size of the mouse, this can be from 5-10 mm. Set the caliper electrodes to the measured thickness and set the electroporator voltage to 12.5 V/mm.</li>
	<li>After 1 min, place the caliper electrodes around the lower limb. The electrodes should be snug but not overly tight. Deliver 5 square-wave pulses, with 20 ms duration and 200 ms intervals (muscle should twitch with each pulse).</li>
	<li>Close the incision using disposable 4/0 non-absorbable nylon sutures.</li>
	<li>Repeat with the alternate limb or leave the limb untouched as absolute control.</li>
	<li>Remove the mouse from anesthesia and allow it to recover on a heating pad set to 37 &#176;C. Administer an appropriate subcutaneous analgesic&#160;immediately after surgery and 12-24 h following surgery. Once recovered, return the mouse to its cage. 
	NOTE: Previous studies have shown a muscle contractility deficit in the TA immediately after electroporation and that contractile recovery occurs over the course of 3 days13,15. For this reason, the analysis of both the TA and EDL muscles for histology, protein expression, or muscle contractility is conducted 3-10 days following electroporation. Prolonged expression of EGFP has been observed up to 3 weeks following the procedure13.</li>
</ol>

<ol><li>Dodd, S., Hain, B., Judge, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Hsp70+prevents+disuse+muscle+atrophy+in+senescent+rats%5BTitle%5D)+AND+%22Biogerontology%22%5BJournal%5D)">Hsp70 prevents disuse muscle atrophy in senescent rats.</a> Biogerontology. 10, 605-611 (2009).</li>
<li>Dodd, S. L., Gagnon, B. J., Senf, S. M., Hain, B. A., Judge, A. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Ros-mediated+activation+of+NF-kappaB+and+Foxo+during+muscle+disuse%5BTitle%5D)+AND+%22Muscle+and+Nerve%22%5BJournal%5D)">Ros-mediated activation of NF-kappaB and Foxo during muscle disuse.</a> Muscle and Nerve. 41 (1), 110-113 (2010).</li>
<li>Dodd, S. L., Hain, B., Senf, S. M., Judge, A. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Hsp27+inhibits+IKK%CE%B2-induced+NF-%CE%BAB+activity+and+skeletal+muscle+atrophy%5BTitle%5D)+AND+%22The+FASEB+Journal%22%5BJournal%5D)">Hsp27 inhibits IKKβ-induced NF-κB activity and skeletal muscle atrophy.</a> The FASEB Journal. 23 (10), 3415-3423 (2009).</li>
<li>Hain, B. A., Dodd, S. L., Judge, A. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((IkappaBalpha+degradation+is+necessary+for+skeletal+muscle+atrophy+associated+with+contractile+claudication%5BTitle%5D)+AND+%22American+Journal+of+Physiology+Regulatory%2C+Integregrative+and+Comparative+Physiology%22%5BJournal%5D)">IkappaBalpha degradation is necessary for skeletal muscle atrophy associated with contractile claudication.</a> American Journal of Physiology Regulatory, Integregrative and Comparative Physiology. 300 (3), 595-604 (2011).</li>
<li>Houston, F. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Heat+shock+protein+70+overexpression+does+not+attenuate+atrophy+in+botulinum+neurotoxin+type+A-treated+skeletal+muscle%5BTitle%5D)+AND+%22Journal+of+Applied+Physiology%22%5BJournal%5D)">Heat shock protein 70 overexpression does not attenuate atrophy in botulinum neurotoxin type A-treated skeletal muscle.</a> Journal of Applied Physiology. 119 (1), 83-92 (2015).</li>
<li>Reed, S. A., Sandesara, P. B., Senf, S. M., Judge, A. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Inhibition+of+FoxO+transcriptional+activity+prevents+muscle+fiber+atrophy+during+cachexia+and+induces+hypertrophy%5BTitle%5D)+AND+%22The+FASEB+Journal%22%5BJournal%5D)">Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.</a> The FASEB Journal. 26 (3), 987-1000 (2012).</li>
<li>Senf, S. M., Dodd, S. L., McClung, J. M., Judge, A. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Hsp70+overexpression+inhibits+NF-kappaB+and+Foxo3a+transcriptional+activities+and+prevents+skeletal+muscle+atrophy%5BTitle%5D)+AND+%22The+FASEB+Journal%22%5BJournal%5D)">Hsp70 overexpression inhibits NF-kappaB and Foxo3a transcriptional activities and prevents skeletal muscle atrophy.</a> The FASEB Journal. 22 (11), 3836-3845 (2008).</li>
<li>Blaveri, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Patterns+of+repair+of+dystrophic+mouse+muscle%3A+studies+on+isolated+fibers%5BTitle%5D)+AND+%22Developmental+Dynamics%22%5BJournal%5D)">Patterns of repair of dystrophic mouse muscle: studies on isolated fibers.</a> Developmental Dynamics. 216 (3), 244-256 (1999).</li>
<li>Fewell, J. G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Gene+therapy+for+the+treatment+of+hemophilia+B+using+PINC-formulated+plasmid+delivered+to+muscle+with+electroporation%5BTitle%5D)+AND+%22Molecular+Therapy%22%5BJournal%5D)">Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation.</a> Molecular Therapy. 3 (4), 574-583 (2001).</li>
<li>Wolff, J. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Direct+gene+transfer+into+mouse+muscle+in+vivo%5BTitle%5D)+AND+%22Science%22%5BJournal%5D)">Direct gene transfer into mouse muscle in vivo.</a> Science. 247 (4949), 1465-1468 (1990).</li>
<li>Aihara, H., Miyazaki, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Gene+transfer+into+muscle+by+electroporation+in+vivo%5BTitle%5D)+AND+%22Nature+Biotechnology%22%5BJournal%5D)">Gene transfer into muscle by electroporation in vivo.</a> Nature Biotechnology. 16 (9), 867-870 (1998).</li>
<li>Mir, L. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((High-efficiency+gene+transfer+into+skeletal+muscle+mediated+by+electric+pulses%5BTitle%5D)+AND+%22Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America%22%5BJournal%5D)">High-efficiency gene transfer into skeletal muscle mediated by electric pulses.</a> Proceedings of the National Academy of Sciences of the United States of America. 96 (8), 4262-4267 (1999).</li>
<li>Schertzer, J. D., Plant, D. R., Lynch, G. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Optimizing+plasmid-based+gene+transfer+for+investigating+skeletal+muscle+structure+and+function%5BTitle%5D)+AND+%22Molecular+Therapy%22%5BJournal%5D)">Optimizing plasmid-based gene transfer for investigating skeletal muscle structure and function.</a> Molecular Therapy. 13 (4), 795-803 (2006).</li>
<li>Hain, B. A., Xu, H., Waning, D. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Loss+of+REDD1+prevents+chemotherapy-induced+muscle+atrophy+and+weakness+in+mice%5BTitle%5D)+AND+%22Journal+of+Cachexia%2C+Sarcopenia+and+Muscle%22%5BJournal%5D)">Loss of REDD1 prevents chemotherapy-induced muscle atrophy and weakness in mice.</a> Journal of Cachexia, Sarcopenia and Muscle. 12 (6), 1597-1612 (2021).</li>
<li>Schertzer, J. D., Lynch, G. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Plasmid-based+gene+transfer+in+mouse+skeletal+muscle+by+electroporation%5BTitle%5D)+AND+%22Methods+in+Molecular+Biology%22%5BJournal%5D)">Plasmid-based gene transfer in mouse skeletal muscle by electroporation.</a> Methods in Molecular Biology. 433, 115-125 (2008).</li>
<li>Roche, J. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Physiological+and+histological+changes+in+skeletal+muscle+following+in+vivo+gene+transfer+by+electroporation%5BTitle%5D)+AND+%22American+Journal+of+Physiology%3A+Cell+Physiology%22%5BJournal%5D)">Physiological and histological changes in skeletal muscle following in vivo gene transfer by electroporation.</a> American Journal of Physiology: Cell Physiology. 301 (5), 1239-1250 (2011).</li>
<li>Hain, B. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Zoledronic+Acid+Improves+Muscle+Function+in+Healthy+Mice+Treated+with+Chemotherapy%5BTitle%5D)+AND+%22Journal+of+Bone+and+Mineral+Research%22%5BJournal%5D)">Zoledronic Acid Improves Muscle Function in Healthy Mice Treated with Chemotherapy.</a> Journal of Bone and Mineral Research. 35 (2), 368-381 (2020).</li>
<li>Hain, B. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((REDD1+deletion+attenuates+cancer+cachexia+in+mice%5BTitle%5D)+AND+%22Journal+of+Applied+Physiology%22%5BJournal%5D)">REDD1 deletion attenuates cancer cachexia in mice.</a> Journal of Applied Physiology. 131 (6), 1718-1730 (2021).</li>
<li>Hain, B. A., Xu, H., Wilcox, J. R., Mutua, D., Waning, D. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Chemotherapy-induced+loss+of+bone+and+muscle+mass+in+a+mouse+model+of+breast+cancer+bone+metastases+and+cachexia%5BTitle%5D)+AND+%22Journal+of+Cachexia%2C+Sarcopenia+and+Muscle+Rapid+Communications%22%5BJournal%5D)">Chemotherapy-induced loss of bone and muscle mass in a mouse model of breast cancer bone metastases and cachexia.</a> Journal of Cachexia, Sarcopenia and Muscle Rapid Communications. 2 (1), (2019).</li>
<li>Waning, D. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Excess+TGF-beta+mediates+muscle+weakness+associated+with+bone+metastases+in+mice%5BTitle%5D)+AND+%22Nature+Medicine%22%5BJournal%5D)">Excess TGF-beta mediates muscle weakness associated with bone metastases in mice.</a> Nature Medicine. 21, 1262-1271 (2015).</li>
<li>Bonetto, A., Andersson, D. C., Waning, D. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Assessment+of+muscle+mass+and+strength+in+mice%5BTitle%5D)+AND+%22Bonekey+Reports%22%5BJournal%5D)">Assessment of muscle mass and strength in mice.</a> Bonekey Reports. 4, 732(2015).</li>
<li>Senf, S. M., Dodd, S. L., Judge, A. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((FOXO+signaling+is+required+for+disuse+muscle+atrophy+and+is+directly+regulated+by+Hsp70%5BTitle%5D)+AND+%22American+Journal+of+Physiology+Cell+Physiology%22%5BJournal%5D)">FOXO signaling is required for disuse muscle atrophy and is directly regulated by Hsp70.</a> American Journal of Physiology Cell Physiology. 298 (1), 38-45 (2010).</li>
<li>Rana, Z. A., Ekmark, M., Gundersen, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Coexpression+after+electroporation+of+plasmid+mixtures+into+muscle+in+vivo%5BTitle%5D)+AND+%22Acta+Physiologica%22%5BJournal%5D)">Coexpression after electroporation of plasmid mixtures into muscle in vivo.</a> Acta Physiologica. 181 (2), 233-238 (2004).</li>
<li>Sokolowska, E., Blachnio-Zabielska, A. U. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+Critical+Review+of+Electroporation+as+A+Plasmid+Delivery+System+in+Mouse+Skeletal+Muscle%5BTitle%5D)+AND+%22Integrative+Journal+of+Molecular+Science%22%5BJournal%5D)">A Critical Review of Electroporation as A Plasmid Delivery System in Mouse Skeletal Muscle.</a> Integrative Journal of Molecular Science. 20 (11), (2019).</li>
<li>Molnar, M. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Factors+influencing+the+efficacy%2C+longevity%2C+and+safety+of+electroporation-assisted+plasmid-based+gene+transfer+into+mouse+muscles%5BTitle%5D)+AND+%22Molecular+Therapy%22%5BJournal%5D)">Factors influencing the efficacy, longevity, and safety of electroporation-assisted plasmid-based gene transfer into mouse muscles.</a> Molecular Therapy. 10 (1), 447-455 (2004).</li>
</ol>

B.A.H. and D.L.W claim no conflicts of interest.

In vivo gene transfer in skeletal muscle enhanced by electroporation is a useful and relatively simple tool for modulating protein expression in muscle. We have shown the steps required to achieve efficient gene transfer in the EDL and TA muscles and demonstrated that contractility measurement of the EDL is viable following the procedure. This technique does not require more complicated viral vectors and allows for the comparison of transfected and non-transfected muscle fiber cross-sectional area in a single mu...

Plasmid DNA electroporation into skeletal muscle in vivo is an important tool for assessing changes in skeletal muscle physiology and molecular signaling by modulating gene expression in a variety of physiological and pathophysiological conditions1,2,3,4,5,6,7,8,9. Experimental gene transfer into skeletal muscle was demonstrated as early as 1990 by Wolff et al., where both RNA and DNA were successfully transferred without electroporation, and luciferase expression was maintained for at least 2 months10. The relatively low transfection efficiency with injection only is problematic, and Aihara and Miyazaki demonstrated increased gene transfer with electroporation in 1998 by electroporating a pCAGGS-IL-5 construct into the tibialis anterior (TA) muscle and measuring serum IL-5 expression11. Since that time, many studies have investigated the efficacy of different DNA concentrations, volumes, and electroporation parameters to ensure maximal gene transfer efficiency. Mir et al. tested different electroporation parameters, including voltage, pulse number, pulse duration, and frequency, as well as DNA concentration, and determined that greater voltage, pulse number, and DNA concentration all contributed to increased electroporation efficiency12. A major caveat to high electroporation voltage is that, while it facilitates increased DNA uptake into myofibers, it also causes muscle damage, which can confound results. Schertzer et al. showed that electroporation at 200 V caused damage in around 50% of myofibers 3 days after electroporation, whereas only 10% of myofibers were damaged at 50 V13. We have taken into consideration the variables affecting efficient DNA transfer versus muscle damage and found that a voltage of 125 V per centimeter of caliper width is sufficient to accomplish effective gene transfer.
Analysis of muscle fiber cross-sectional area and whole muscle contractility after electroporation are important aspects of the method for measuring changes in muscle size and function due to gene modulation. We and others have previously demonstrated that electroporation of control vectors alone does not cause a decrease in myofiber area. The green fluorescent protein (EGFP) construct was a useful fluorescent indicator of DNA transfection in these studies13,14. A number of studies have investigated in situ contractility of the TA after electroporation and found varying results. One study showed that 75 V/cm electroporation caused about a 30% reduction in tetanic force 3 days post-electroporation, and by 7 days post-electroporation, tetanic force was back to the control level, while 50 V/cm electroporation did not compromise force13,15. Another study showed that there was a 30% loss of tetanic force 3 h after 180 V/cm electroporation, which recovered to the sham force levels after 7 days16.
In the following detailed procedure, we demonstrate injection and electroporation of a pcDNA3-EGFP plasmid in the TA and extensor digitorum longus (EDL) muscles of mice. We also demonstrate that this method does not affect EDL whole-muscle contractility. The aim is to demonstrate efficient plasmid uptake into myofibers without causing loss of function.

<table><tbody><tr><td>4-0 Nylon suture (non-absorbable)</td><td>Ethicon</td><td>662G</td><td>Suture to close skin incision</td></tr><tr><td>50&amp;micro;l Hamilton syringe</td><td>Hamilton</td><td>80501</td><td>microsyringe</td></tr><tr><td>C57BLl/6NHsd mice</td><td>Envigo</td><td>044</td><td>12 week-old female mice used for experimentation</td></tr><tr><td>Caliper Electrode</td><td>BTX</td><td>45-0102</td><td>1.0cm x 1.0cm stainless steel</td></tr><tr><td>Dynamic Muscle Control Data Acquisition/analysis</td><td>Aurora Scientific</td><td>605A</td><td>Software used for muscle contractility measurement and analysis</td></tr><tr><td>ECM 830 Electroporation System</td><td>BTX</td><td>45-0662</td><td>electroporator</td></tr><tr><td>EndoFree Plasmid Maxi Kit</td><td>Qiagen</td><td>12362</td><td>Plasmid purification kit</td></tr><tr><td>Extra Narrow Scissors</td><td>Fine Science Tools</td><td>14088-10</td><td>Scissors for blunt dissection</td></tr><tr><td>Force Transducer</td><td>Aurora Scientific</td><td>407A</td><td>To measure force from EDL</td></tr><tr><td>Micro-Masquito Hemastats</td><td>Fine Science Tools</td><td>13010-12</td><td>Hemastats for surturing</td></tr><tr><td>pcDNA3.1 mammalian expression vector</td><td>Fisher Scientific</td><td>V79020</td><td>Control Vector</td></tr><tr><td>pcDNA3-EGFP expression plasmid</td><td>Addgene</td><td>13031</td><td>Plasmid for GFP expression</td></tr><tr><td>Semken curved forceps</td><td>Fine Science Tools</td><td>11009-13</td><td>Forceps for surgery</td></tr><tr><td>Surgical blades stainless steel no. 10</td><td>Becton Dickinson</td><td>37 1210</td><td>Scalpel blades</td></tr><tr><td>Tissue-Tek O.C.T. media</td><td>VWR</td><td>25608-930</td><td>Freezing media for histology</td></tr><tr><td>Wheat Germ Agglutinin- Texas Red</td><td>Thermo-Fisher Scientific</td><td>W21405</td><td>Membrane staining for muscle cross section</td></tr></tbody></table>

electroporation of plasmid dna into mouse skeletal muscle

Electroporation of Plasmid DNA into Mouse Skeletal Muscle

Transient gene expression modulation in murine skeletal muscle by plasmid electroporation is a useful tool for assessing normal and pathological physiology. Overexpression or knockdown of target genes enables investigators to manipulate individual molecular events and, thus, better understand the mechanisms that impact muscle mass, muscle metabolism, and contractility. In addition, electroporation of DNA plasmids that encode fluorescent tags allows investigators to measure changes in subcellular localization of proteins in skeletal muscle in vivo. A key functional assessment of skeletal muscle includes the measurement of muscle contractility. In this protocol, we demonstrate that whole muscle contractility studies are still possible after plasmid DNA injection, electroporation, and gene expression modulation. The goal of this instructional procedure is to demonstrate the step-by-step method of DNA plasmid electroporation into mouse skeletal muscle to facilitate uptake and expression in the myofibers of the tibialis anterior and extensor digitorum longus muscles, as well as to demonstrate that skeletal muscle contractility is not compromised by injection and electroporation.

Electroporation to facilitate gene transfer in skeletal muscle is a useful technique used to evaluate changes in muscle physiology. We have demonstrated a detailed, step-by-step procedure to accomplish efficient gene transfer in both the TA and EDL muscles. Differences in transfection efficiency occur due to a number of variables. Among these variables are electroporation parameters (pulses, voltage, pulse duration, etc.), gene construct size, and concentration/volume of DNA injected. We have previously shown that electr...

Electroporation of plasmid DNA into skeletal muscle is a viable method to modulate gene expression without compromising muscle contractility in mice.

Transient gene expression modulation in murine skeletal muscle by plasmid electroporation is a useful tool for assessing normal and pathological ...

electroporation-of-plasmid-dna-into-mouse-skeletal-muscle

Research

JoVE Journal

Biology

We describe detailed procedures for the efficient transfection of plasmid DNA into the fibers of foot muscles of live mice using electroporation and the subsequent visualization of protein expression using fluorescence microscopy.

DNA Transfection of Mammalian Skeletal Muscles using In Vivo Electroporation

This video demonstrates the delivery of plasmid DNA into cerebellar neuronal cells of murine embryos using in utero electroporation. This method is useful to gain understanding of in vivo function of genes in normal brain development and the changes in gene expression of neuron cells during tumor progression.

In Utero Electroporation Based Gene Delivery: A Technique to Inject Plasmid DNA into Embryonic Cerebellar Cells of Murine Embryos

The pial surface is a unique progenitor zone in the CNS that is receiving increasing attention.  Herein, we detail a method for rapid genetic manipulation of this progenitor zone using a modified electroporation method.  This procedure can be used for cellular and molecular investigations of cell lineages and signaling pathways involved in cell differentiation and to elucidate the fate and properties of daughter cells.

Neonatal Pial Surface Electroporation

This article describes microinjection and electroporation of mouse testis in vivo as a transfection technique for testicular mouse cells to study unique processes of spermatogenesis. The presented protocol involves steps of glass capillary preparation, microinjection via the efferent duct, and transfection by electroporation.

In Vivo Microinjection and Electroporation of Mouse Testis

This protocol utilizes electroporation to introduce and express fluorescently labeled proteins in mouse muscle fibers. Following recovery after electroporation, fibers are isolated. Individual fibers are then imaged using high resolution confocal microscopy to visualize muscle structure.

DNA Electroporation, Isolation and Imaging of Myofibers

We describe a novel method for the delivery of DNA plasmid into the urothelial cells of mouse bladder in vivo through urethra catheterization and electroporation. It offers a fast and convenient way for generating autochthonous mouse models of bladder diseases.

Novel Method of Plasmid DNA Delivery to Mouse Bladder Urothelium by Electroporation

This protocol describes microinjection and in vivo electroporation for regionally restricted CRISPR-mediated genome editing in the mouse oviduct.

Somatic Genome-Engineered Mouse Models Using In Vivo Microinjection and Electroporation

Functional site-directed fluorometry is a method to study protein domain motions in real time. Modification of this technique for its application in native cells now allows the detection and tracking of single voltage-sensor motions from voltage-gated Ca2+ channels in murine isolated skeletal muscle fibers.

Functional Site-Directed Fluorometry in Native Cells to Study Skeletal Muscle Excitability

Here, we present a protocol that combines in vivo electroporation and denervation of the cranial levator auris longus (LAL) muscle. This procedure enables the study of the potential role of muscle-derived proteins in the regeneration of the neuromuscular synapse.

Combined In Vivo Electroporation and Short&#45;Term Reinnervation of the Cranial Levator Auris Longus Skeletal Muscle

Here, we present a gene therapy approach that delivers ABE-coated chitosan directly to the bone marrow by intraosseous injection.

Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids

Learn electroporation-mediated gene transfer in mouse skeletal muscle using C57BL/6 mice. This technique enables efficient plasmid DNA delivery without compromising muscle contractility for physiology research.

Electroporation of Plasmid DNA into Mouse Skeletal Muscle

Explore More Videos